Results 91 to 100 of about 29,158 (227)

Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease

open access: yes, 2017
Claudia Friedl,1 Emanuel Zitt2 1Department of Internal Medicine, Clinical Division of Nephrology, Medical University of Graz, Graz, 2Department of Nephrology and Dialysis, Feldkirch Academic Teaching Hospital, Feldkirch, Austria Abstract: Secondary ...
Friedl C, Zitt E
core  

Chronic Liver Disease, Liver Damage and Liver Failure After Hypoabsorptive Bariatric Surgery: A Dose‐Dependent Relationship and Multisystemic Consequences

open access: yesEuropean Journal of Clinical Investigation, Volume 56, Issue 6, June 2026.
ABSTRACT Background/Aims Metabolic bariatric surgery remains the most potent weapon we have against severe obesity and its metabolic consequences. Yet, its effects on the liver are far from uniform. Although restrictive and mixed procedures like sleeve gastrectomy and Roux‐en‐Y gastric bypass consistently improve metabolic dysfunction‐associated ...
Francesco Saverio Papadia   +3 more
wiley   +1 more source

A Swelling in the Mouth in a Chronic Hemodialysis Patient

open access: yesCase Reports in Nephrology, 2016
Oral manifestations of severe secondary hyperparathyroidism include maxillary and mandibular deformities, brown tumors, dental abnormalities, and metastatic calcification of soft tissues.
Arnaud Devresse   +3 more
doaj   +1 more source

Recurrent tertiary hyperparathyroidism due to supernumerary parathyroid glands in a patient receiving long-term hemodialysis: a case report

open access: yesBMC Endocrine Disorders, 2019
Background Renal hyperparathyroidism is a common complication of chronic kidney disease (CKD) or end-stage renal disease (ESRD) characterized by elevated parathyroid hormone levels secondary to derangements in the homeostasis of calcium, phosphate, and ...
Tsai-Sung Tai   +3 more
doaj   +1 more source

Treatment of secondary hyperparathyroidism in kidney disease: what we know and do not know about use of calcimimetics and vitamin D analogs

open access: yes, 2008
James B Wetmore1, L Darryl Quarles1,21Department of Medicine, Division of Nephrology, University of Kansas Medical Center, Kansas City, KS, USA; 2The Kidney Institute, University of Kansas Medical Center, Kansas City, KS, USAAbstract: There is a growing ...
James B Wetmore, L Darryl Quarles
core  

Regional Variation of Aetiologies and Complications in Chronic Kidney Disease From Thailand (THAI‐CKD Registry)

open access: yesNephrology, Volume 31, Issue 6, June 2026.
This study from the THAI‐CKD registry evaluated regional and KDIGO‐based variations in chronic kidney disease (CKD) aetiologies and complications among 3371 adults with CKD G3‐G5 across six regions of Thailand. Diabetic nephropathy was the leading aetiology, followed by hypertensive nephrosclerosis and CKD of unknown aetiology.
Kavita Jintanapramote   +23 more
wiley   +1 more source

Bradycardia secondary to primary hyperparathyroidism

open access: yesJournal of International Medical Research, 2019
Clinical doctors rarely associate hyperparathyroidism with significant bradyarrhythmia. We report a rare case of a patient initially misdiagnosed with primary sick sinus syndrome, which was eventually shown to be secondary to primary hyperparathyroidism.
Fei Liu   +3 more
doaj   +1 more source

Quantification of SARM1 NADase Activity in Human Peripheral Blood Mononuclear Cells

open access: yesThe FASEB Journal, Volume 40, Issue 9, 15 May 2026.
Proposed model for NAD+ metabolism in (A) control and (B) SARM1 activated PBMCs. In native form, 3‐AP and Vacor compete with NAM as an alternative substrate for NAMPT. This consequently decreases generation of NMN and biosynthesis of NAD+ is limited by both a reduction in precursor NMN and direct inhibition of NMNAT by Vacor‐MN and 3‐AP‐MN.
Lila F. Dabill   +5 more
wiley   +1 more source

[Secondary hyperparathyroidism].

open access: yesChirurgia (Bucharest, Romania : 1990), 1996
Secondary (renal) hyperparathyroidism appears in chronic renal failure, sometimes in patients on chronic dialysis. Other causes includes rickets and osteomalacia. These diseases are associated with poor calcium and vitamin D absorbtion from the small bowel.
M R, Diaconescu   +5 more
openaire   +1 more source

Lack of vitamin D signalling per se does not aggravate cardiac functional impairment induced by myocardial infarction in mice.

open access: yesPLoS ONE, 2018
Epidemiological studies have linked vitamin D deficiency to an increased incidence of myocardial infarction and support a role for vitamin D signalling in the pathophysiology of myocardial infarction.
Kristopher Ford   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy